Evidence map›Paper›PMID 25922154›Full record

ReviewAnnals of the New York Academy of Sciences2016

Imaging of cerebrovascular disorders: precision medicine and the collaterome.

David S Liebeskind, Edward Feldmann

Abstract readReview
In one paragraph

Review in Annals of the New York Academy of Sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Mapping the collaterome for precision cerebrovascular health: Theranostics in the continuum of stroke and dementia.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2018
    Review
  4. Toward precision medicine in neurological diseases.Annals of translational medicine · 2016
    Review
  5. Article
  6. Big Data Analytics in Healthcare.BioMed research international · 2015
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

David S LiebeskindNeurovascular Imaging Research Core and the University of California, Los Angeles Stroke Center, Los Angeles, California.
Edward FeldmannBaystate Medical Center, Springfield, Massachusetts.

Funding

Hypothermia in Acute Stroke with Thrombolysis Imaging Evaluation of RevascularizaR01NS077706 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIEBESKIND, DAVID SIGMUND · 2012 to 2013
$1.1M
Modeling of Collateral Perfusion in the Ischemic BrainK24NS072272 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIEBESKIND, DAVID SIGMUND · 2011 to 2015
$939k
2nd International Symposium on Collaterals to the BrainR13NS089280 · NINDS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LIEBESKIND, DAVID SIGMUND · 2014 to 2014
$15k
NINDS NIH HHS K24 NS072272NINDS NIH HHS R01 NS077706NINDS NIH HHS R13 NS089280
6 · The paper itself

Abstract

Imaging of stroke and neurovascular disorders has profoundly enhanced clinical practice and related research during the last 40 years since the introduction of computed tomography (CT) and magnetic resonance imaging (MRI) enabled mapping of the brain. We highlight recent advances in neurovascular imaging. We describe how the convergence of readily available data and new clinical trial paradigms will recast our methods for studying the neurovascular patient. The application of a precision medicine approach to the collaterome, a comprehensive synthesis of neurovascular pathophysiology, will entail novel methods for clinical trial randomization, collection of routine and clinical trial imaging results, data archiving, and analysis.

Indexed as

Cerebrovascular DisordersClinical Trials as TopicCollateral CirculationDiagnostic ImagingHumansMagnetic Resonance ImagingPrecision MedicineTomography, X-Ray Computedcollateralsdata scienceimagingstroke

Identifiers

PMID25922154
PMCPMC4624622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.